1. Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries
- Author
-
Gilmer, Todd, O'Connor, Patrick J., Schiff, Jeffrey S., Taylor, Gretchen, Vazquez-Benitez, Gabriela, Garrett, Joyce E., Vue-Her, Houa, Rinn, Sarah, Anderson, Julie, and Desai, Jay
- Subjects
Beneficiaries -- Analysis ,Health care costs -- Analysis ,Medicaid -- Analysis ,Business ,Health care industry - Abstract
Objective. To examine the cost-effectiveness of a community-based Diabetes Prevention Program (DPP) for Medicaid beneficiaries from the perspective of the health care sector.Data Sources/Study Setting. A total of 847 Medicaid enrollees at high risk for type 2 diabetes participating in a community-based DPP.Study Design. Pre- and post clinical outcome and cost data were used as inputs into a validated diabetes simulation model. The model was used to evaluate quality-adjusted life years (QALYs) and health care costs over a 40-year time horizon from the perspective of the health care sector.Data Collection/Extraction Methods. Clinical outcome and cost data were derived from a study examining the effect of financial incentives on weight loss.Principal Findings. Study participants lost an average of 4.2 lb (p < .001) and increased high-density lipoprotein cholesterol by 1.75 mg/dl (p = .002). Intervention costs, which included financial incentives for participation and weight loss, were $915 per participant. The incremental cost-effectiveness ratio was estimated to be $14,011 per QALY but was sensitive to the time horizon studied.Conclusions. Widespread adoption of community-based DPP has the potential to reduce diabetes and cardiovascular-related morbidity and mortality for low-income persons at high risk for diabetes and may be a cost-effective investment for Medicaid programs.Key Words. Cost-effectiveness, Medicaid, health care costs, Diabetes is a common and costly chronic disease that disproportionally affects minority and low-income populations. In 2012, the 22.3 million U.S. residents with diabetes incurred an economic burden of $176 [...]
- Published
- 2018
- Full Text
- View/download PDF